I'm speechless.
Firstly because we have an approval.
Secondly because it's deemed to be not price sensitive!
This was supposed to be the saviour of MYX back in 2018-2021 (until Nextstellis came along).
From memory the market size was supposed to over $900M but is now $580M.
MYX have to pay Mithra $6M euro now with another $1.6M euro when it actually launches so I think it's safe to assume that we can write off any profits in the short term. I'm guessing the fact that we're so late to market behind other generic manufacturers means that long term profits are likely to be as abysmal as our other generic products.
The debacle of MYX continues.
- Forums
- ASX - By Stock
- MYX
- Ann: FDA approval of HALOETTE, a generic version of NUVARING
Ann: FDA approval of HALOETTE, a generic version of NUVARING, page-2
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.59 |
Change
-0.220(4.57%) |
Mkt cap ! $390.4M |
Open | High | Low | Value | Volume |
$4.79 | $4.79 | $4.57 | $211.0K | 45.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 684 | $4.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.61 | 106 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 684 | 4.580 |
1 | 557 | 4.570 |
1 | 557 | 4.560 |
1 | 557 | 4.550 |
2 | 663 | 4.540 |
Price($) | Vol. | No. |
---|---|---|
4.610 | 106 | 1 |
4.620 | 106 | 1 |
4.630 | 106 | 1 |
4.640 | 106 | 1 |
4.650 | 106 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online